| Literature DB >> 31607996 |
Anna-Lena Zietlow1, Nora Nonnenmacher2, Corinna Reck3, Beate Ditzen1, Mitho Müller3.
Abstract
There is growing evidence that even milder forms of maternal stress or anxiety during pregnancy affect the fetus causing possible long-term consequences for infant and child development. The mechanisms through which prenatal maternal stress may affect the unborn are not yet entirely clarified. Due to limited self-regulatory skills after birth, infants depend on sensitive behavior of their parents to regulate affective states and physiological arousal. Dyadic affect regulation has been linked to various developmental patterns up to adolescence and thereby represents a key element of early social relationships. Aim of the study was to evaluate possible long-term consequences of emotional stress during pregnancy and postpartum anxiety disorders, as well as infant postpartum cortisol reactivity on mother-child-interaction at pre-school age. The sample comprised of N = 63 mother-infant dyads at study entry, n = 28 diagnosed with postpartum anxiety disorders according to the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV), n = 35 were healthy controls. Mothers were interviewed with the Structured Clinical Interview for DSM-IV Disorders at an average infant age of M = 4.1 months and filled out a questionnaire regarding emotional stress during pregnancy. Further, they were videotaped during the Face-to-Face-Still-Face paradigm (FFSF), a widely used mild socio-emotional stressor for infants. To determine infant stress-reactivity, infant salivary cortisol was collected before, immediately after and 20 min after the FFSF. Missing values were estimated by multiple imputations. At the age of M = 5.3 years, mother-child-interaction was re-assessed in a follow-up sample of n = 30 dyads via a free-play situation. Moreover, dimensional measures for anxiety were assessed. Mothers in the clinical group reported significantly higher stress scores than the control group. Infant stress reactivity in the early postpartum period and maternal anxiety symptoms at the 5-year follow-up assessment were significantly associated with dyadic interaction quality at pre-school age. Even though maternal stress during pregnancy did not directly predict mother-child interaction quality at pre-school age, it was significantly correlated with infant cortisol reactivity during postpartum period. Nevertheless, caution should be taken when interpreting the results considering the small sample size.Entities:
Keywords: anxiety disorders; child development; cortisol reactivity; pregnancy; stress
Year: 2019 PMID: 31607996 PMCID: PMC6773887 DOI: 10.3389/fpsyg.2019.02179
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
FIGURE 1Flow chart of recruitment process and case exclusions.
Demographics and tests on comparability of subgroups.
| Infant age at study entry (months)a
| 4.1 (1.4) | 4.0 (1.4) | 4.3 (1.5) | −0.92 (0.36) |
| Gestation age (weeks)b
| 39.5 (1.5) | 39.7 (1.3) | 39.2 (1.6) | 1.31 (0.18) |
| APGAR (average)c
| 9.5 (0.6) | 9.5 (0.6) | 9.5 (0.6) | 0.07 (0.94) |
| Child age at 5-year-follow-up (years)d
| 5.3 (0.4) | 5.3 (0.4) | 5.5 (0.5) | −1.25 (0.22) |
| Female | 42 | 24 | 18 | 0.13e (0.79) |
| Male | 21 | 11 | 10 | |
| Maternal age at study entry (years) f
| 32.4 (5.6) | 33.0 (5.5) | 31.8 (5.6) | 0.89 (0.38) |
| Maternal age at 5-year-follow-up (years) g
| 39.8 (5.6) | 40.2 (5.3) | 39.3 (6.2) | 0.46 (0.65) |
| University degree | 34 | 19 | 15 | 463.0 (0.70) |
| University entrance qualification | 12 | 8 | 4 | |
| High secondary qualification | 14 | 7 | 7 | |
| Low secondary qualification | 3 | 1 | 2 | |
| Married | 42 | 26 | 16 | 2.15h (0.23) |
| Not married | 15 | 6 | 9 | |
Pooled imputation result (averaged over 20 data sets) of missing data.
| C1 (in ng/ml) ( | 1.49 | 0.95 | 0.81 | 2.16 | 1.34 | 1.34 | 0.10 | 7.10 |
| C2 (in ng/ml) ( | 1.15 | 0.60 | 0.73 | 1.58 | 1.31 | 1.27 | 0.10 | 6.50 |
| C3 (in ng/ml) ( | 1.19 | 0.84 | 0.10 | 2.75 | 1.10 | 0.94 | 0.10 | 3.90 |
| PESI 1st trimester (in%) ( | 31.53 | 4.84 | 25.05 | 39.41 | 31.87 | 23.03 | 0.00 | 92.27 |
| PESI 2nd trimester (in%) ( | 30.36 | 4.84 | 23.06 | 37.36 | 30.40 | 21.16 | 0.00 | 89.09 |
| PESI 3rd trimester (in%) ( | 32.17 | 5.08 | 24.21 | 39.04 | 31.70 | 21.49 | 0.00 | 91.27 |
| PESI total score | 30.92 | 4.64 | 24.23 | 37.59 | 31.29 | 20.05 | 2.42 | 86.97 |
| ACQ ( | 1.42 | 0.43 | 1.00 | 2.14 | 1.34 | 0.37 | 1.00 | 2.50 |
| MIA ( | 1.48 | 0.53 | 1.00 | 2.65 | 1.36 | 0.54 | 1.00 | 3.56 |
| MIB ( | 1.29 | 0.32 | 1.00 | 1.93 | 1.15 | 0.26 | 1.00 | 2.12 |
| BSQ ( | 1.79 | 0.66 | 1.05 | 2.85 | 1.71 | 0.60 | 1.00 | 3.53 |
| Anxiety symptoms (composite) | 1.43 | 0.25 | 1.07 | 1.98 | 1.35 | 0.31 | 1.00 | 2.36 |
Mann–Whitney U-tests on differences between the study groups regarding emotional stress during pregnancy (PESI total score), infant cortisol reactivity (AUCI), and dyadic interaction (CIB) at 5 years follow-up.
| Emotional stress (PESI total score) | Original data ( | 19.37 | 1.77 | 52.29 | 4.37 | 40.00 | <0.01 |
| Pooled data ( | 19.37 | 1.77 | 46.18 | 3.66 | 75.86 | <0.01 | |
| Infant cortisol reactivity (AUCI) | Original data ( | –5.56 | 2.89 | –3.18 | 5.19 | 191.00 | 0.66 |
| Pooled data ( | –5.38 | 3.22 | 0.18 | 3.88 | 374.52 | 0.19 | |
| Dyadic negative states (CIB) | Original data ( | 1.54 | 0.18 | 1.94 | 0.26 | 80.50 | 0.21 |
| Dyadic reciprocity (CIB) | Original data ( | 3.75 | 0.14 | 3.54 | 0.26 | 96.50 | 0.62 |
Generalized linear regression models on infant cortisol reactivity (AUCI) and dyadic negative states and reciprocity (CIB).
| Model 1: infant cortisol reactivity (AUCI) predicted by emotional stress (PESI total score) | original data ( | PESI total score | 0.372 | 0.175 | 0.029 | 0.716 | 4.512 | 0.034 |
| Intercept | –12.350 | 5.373 | –22.881 | –1.818 | 5.282 | 0.022 | ||
| Scale | 190.893 | 44.994 | 120.270 | 302.984 | / | / | ||
| pooled data ( | PESI total score | 0.235 | 0.112 | 0.015 | 0.456 | 5.303 | 0.036 | |
| Intercept | –10.272 | 4.459 | –19.019 | –1.525 | 6.323 | 0.021 | ||
| Scale | 329.473 | 74.212 | 182.782 | 476.163 | / | / | ||
| Model 2: dyadic negative states (CIB) predicted by anxiety symptoms at the 5-year follow-up and infant cortisol reactivity (AUCI) | original data ( | Anxiety symptoms (5-year follow-up) | 1.202 | 0.431 | 0.356 | 2.047 | 7.764 | 0.005 |
| AUCI | 0.016 | 0.004 | 0.009 | 0.023 | 20.499 | <0.001 | ||
| Intercept | 0.193 | 0.591 | –0.966 | 1.352 | 0.106 | 0.745 | ||
| Scale | 0.474 | 0.162 | 0.242 | 0.928 | / | / | ||
| Pooled data ( | Anxiety symptoms (5-year follow-up) | 1.280 | 0.404 | 0.488 | 2.072 | 10.072 | 0.002 | |
| AUCI | 0.012 | 0.004 | 0.005 | 0.020 | 13.186 | 0.002 | ||
| Intercept | 0.077 | 0.529 | –0.959 | 1.114 | 0.042 | 0.884 | ||
| Scale | 0.421 | 0.120 | 0.186 | 0.656 | / | / | ||
| Model 3: dyadic reciprocity (CIB) predicted by anxiety symptoms at the 5-year follow-up and infant cortisol reactivity (AUCI) | original data ( | Anxiety symptoms (5-year follow-up) | –1.196 | 0.336 | –1.854 | –0.537 | 12.659 | <0.001 |
| AUCI | –0.009 | 0.004 | –0.018 | –0.001 | 4.928 | 0.026 | ||
| Intercept | 5.197 | 0.482 | 4.253 | 6.142 | 116.330 | <0.001 | ||
| Scale | 0.293 | 0.100 | 0.150 | 0.574 | / | / | ||
| Pooled data ( | Anxiety symptoms (5-year follow-up) | –1.261 | 0.325 | –1.897 | –0.625 | 15.168 | <0.001 | |
| AUCI | –0.010 | 0.004 | –0.018 | –0.002 | 7.577 | 0.010 | ||
| Intercept | 5.269 | 0.440 | 4.407 | 6.131 | 144.644 | <0.001 | ||
| Scale | 0.288 | 0.082 | 0.128 | 0.448 | / | / |
Descriptive statistics on infant cortisol values by group and measurement time.
| Original data | C1 (in ng/ml) | Control group | 1.52 | 1.50 | 26 |
| Clinical group | 1.15 | 0.93 | 16 | ||
| Total | 1.38 | 1.31 | 42 | ||
| C2 (in ng/ml) | Control group | 1.40 | 1.45 | 26 | |
| Clinical group | 1.12 | 0.85 | 16 | ||
| Total | 1.29 | 1.25 | 42 | ||
| C3 (in ng/ml) | Control group | 1.13 | 0.98 | 26 | |
| Clinical group | 0.86 | 0.76 | 16 | ||
| Total | 1.03 | 0.90 | 42 | ||
| Pooled dataa | C1 (in ng/ml) | Control group | 1.59 | 1.49 | 35 |
| Clinical group | 1.03 | 1.06 | 28 | ||
| Total | 1.34 | 1.34 | 63 | ||
| C2 (in ng/ml) | Control group | 1.50 | 1.44 | 35 | |
| Clinical group | 1.06 | 0.97 | 28 | ||
| Total | 1.30 | 1.27 | 63 | ||
| C3 (in ng/ml) | Control group | 1.18 | 1.03 | 35 | |
| Clinical group | 0.99 | 0.81 | 28 | ||
| Total | 1.10 | 0.94 | 63 | ||